Filing Analysis
Securities Offering
Filed Mar 13, 2026
MEDIUM
Bone Biologics Corp has filed a prospectus supplement to sell up to $1,064,000 of common stock through an 'at the market' (ATM) offering program. The sales will be facilitated by H.C. Wainwright & Co., LLC as the sales agent under an existing agreement.
Red Flags
- Ongoing dilution risk from 'at the market' equity sales.
- Reliance on General Instruction I.B.6 indicates the company's public float is likely below $75 million.
- Frequent capital raising activity, having already utilized $1.7 million from a previous shelf registration.
Key Facts
- Offering amount is up to $1,064,000 in common stock.
- Sales agent is H.C. Wainwright & Co., LLC.
- The offering is conducted under General Instruction I.B.6 of Form S-3 (the 'baby shelf' rule).
- Company previously sold approximately $1.7 million of common stock under a prior registration statement.
- The Shares will be issued pursuant to a shelf registration statement on Form S-3 (File No. 333-288290) effective as of September 2, 2025.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.